Havrilesky, L. J., Alvarez Secord, A., Darcy, K. M., Armstrong, D. K., & Kulasingam, S. (2008). Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study. American Society of Clinical Oncology.
Citação norma ChicagoHavrilesky, Laura J., Angeles Alvarez Secord, Kathleen M. Darcy, Deborah K. Armstrong, and Shalini Kulasingam. Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study. American Society of Clinical Oncology, 2008.
Deismireacht MLAHavrilesky, Laura J., et al. Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study. American Society of Clinical Oncology, 2008.